Form 4: Abeona Therapeutics SVP Sells Shares to Cover Tax Obligations
Insider Transaction Report
Brendan M. O'Malley, SVP and Chief Legal Officer of Abeona Therapeutics Inc., sold 17,428 shares of common stock on July 9, 2025, to cover tax obligations related to restricted stock vesting.
Summary
- Brendan M. O'Malley, SVP and Chief Legal Officer of Abeona Therapeutics Inc. (ABEO), reported a sale of 17,428 shares of common stock.
- The transaction occurred on July 9, 2025, at a weighted average price of $5.8557 per share, with individual sales ranging from $5.78 to $5.92.
- The sale was executed to cover tax obligations associated with the vesting of restricted stock awards.
- Following this transaction, Brendan M. O'Malley beneficially owns 360,817 shares of Abeona Therapeutics Inc. common stock.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned sale.
Sentiment
Score: 5
Explanation: The transaction is neutral as it is a routine, non-discretionary sale to cover tax obligations related to restricted stock vesting, which is a common occurrence for executives.
Positives
- The sale was conducted under a Rule 10b5-1(c) plan, indicating a pre-planned, non-discretionary transaction.
- The underlying reason for the sale was to cover tax obligations associated with the vesting of restricted stock awards, implying the executive received equity compensation.
Management Comments
- The sale reported was to cover tax obligations associated with the vesting of restricted stock awards.
Industry Context
This Form 4 filing reports a routine insider transaction for tax purposes and does not provide broader industry context or trends.
Comparison to Industry Standards
- Not applicable as this document reports an insider transaction, not company performance or financial results.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine, non-discretionary sale for tax purposes, not indicative of a change in management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 07/09/2025 | Date of earliest transaction (sale of common stock) |
| 07/10/2025 | Date the Form 4 was signed and filed |
Keywords
ABEONA THERAPEUTICS, ABEO, Form 4, Insider Transaction, Stock Sale, Tax Obligations, Restricted Stock, Brendan O'Malley, Biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.